Justice Department Briefing — July 23, 2026
Estimated reading time: 5 minutes
1. United States v. Edwards LifeSciences Corp. and Genesis MedTech Group Limited; Proposed Final Judgment and Competitive Impact Statement
Sub: Justice Department, Antitrust Division
2. Bulk Manufacturer of Controlled Substances Application: American Radiolabeled Chem
Sub: Justice Department, Drug Enforcement Administration
Content: American Radiolabeled Chem has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
3. United States, et al. v. OhioHealth Corporation; Proposed Final Judgment and Competitive Impact Statement
Sub: Justice Department, Antitrust Division
4. Agency Information Collection Activities; Proposed eCollection, eComments Requested; Revision of a Previously Approved Collection; Title-Recordkeeping for Partial fills of Prescriptions
Sub: Justice Department
Content: The Drug Enforcement Administration (DEA), Department of Justice (DOJ), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.
5. Agency Information Collection Activities; Proposed eCollection, eComments Requested; Revision of a Previously Approved Collection; Title-Recordkeeping for the Transfer of Electronic Prescriptions in Schedules III-V between Pharmacies
Sub: Justice Department
Content: The Drug Enforcement Administration (DEA), Department of Justice (DOJ), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.
6. Agency Information Collection Activities; Proposed eCollection, eComments Requested; Extension Without Change of a Previously Approved Collection; Title-U.S. Official Order Forms for Schedules I and II Controlled Substances DEA Form 222
Sub: Justice Department
Content: The Drug Enforcement Administration (DEA), Department of Justice (DOJ), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.
Legal Disclaimer
This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
